8-K: American Healthcare REIT Stockholders Affirm Board, Auditor, Executive Pay, and New Equity Plan at Annual Meeting

American Healthcare REIT, Inc. announced that its stockholders approved all four proposals at the 2025 Annual Meeting, including the re-election of nine directors, ratification of Deloitte & Touche, advisory approval of executive compensation, and the adoption of the 2025 Manager Equity Plan.

Summary

• At the 2025 Annual Meeting of Stockholders held on June 25, 2025, American Healthcare REIT, Inc. stockholders voted on four key proposals.
• All nine director nominees, including Jeffrey T. Hanson, Danny Prosky, Mathieu B. Streiff, Scott A. Estes, Brian J. Flornes, Dianne Hurley, Marvin R. O'Quinn, Valerie Richardson, and Wilbur H. Smith III, were re-elected to serve one-year terms expiring at the 2026 Annual Meeting of Stockholders.
• The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2025, was ratified with 138,414,959 shares for, 1,139,417 shares against, and 282,469 shares abstained.
• Stockholders provided advisory (non-binding) approval for the compensation paid to named executive officers for the year ended December 31, 2024, with 109,297,003 shares for, 7,525,316 shares against, 450,207 shares abstained, and 22,564,319 broker non-votes.
• The American Healthcare REIT, Inc. 2025 Manager Equity Plan was approved with 112,586,838 shares for, 4,273,480 shares against, 412,208 shares abstained, and 22,564,319 broker non-votes.

Sentiment

Score: 7

Explanation: The sentiment is generally positive as all management-backed proposals passed, indicating stability and shareholder confidence in the current leadership and strategic direction. However, some dissent was noted in the votes for one director's re-election and executive compensation, preventing a higher score.

Positives

• All four proposals presented at the annual meeting received the requisite stockholder votes for approval, indicating overall shareholder support for the company's governance and strategic direction.
• The re-election of all nine directors provides continuity in the company's leadership and board oversight.
• The ratification of Deloitte & Touche LLP as the independent auditor ensures continued financial oversight and compliance.
• The approval of the 2025 Manager Equity Plan allows the company to use equity incentives to attract, retain, and motivate key personnel, aligning their interests with those of stockholders.

Negatives

• Brian J. Flornes received a notable number of 'Shares Withheld' (16,587,419) for his re-election, indicating some level of shareholder dissent, although he was still elected.
• The advisory vote on named executive officer compensation saw 7,525,316 shares voted 'Against', representing a significant minority of votes, suggesting some shareholder concern regarding executive pay practices.

Future Outlook

The re-elected directors will hold office for a one-year term expiring at the 2026 Annual Meeting of Stockholders. The approved 2025 Manager Equity Plan is now in effect, providing a framework for future equity-based compensation.

Management Comments

• Danny Prosky, Chief Executive Officer and President, signed the report on behalf of American Healthcare REIT, Inc.

Industry Context

This 8-K filing details the routine outcomes of an annual stockholder meeting for a publicly traded Real Estate Investment Trust (REIT) specializing in healthcare properties. The approval of all proposals, including director elections and an equity plan, is consistent with standard corporate governance practices within the REIT sector, reflecting ongoing operational and strategic continuity.

Comparison to Industry Standards

• The re-election of all incumbent directors is a common outcome in corporate annual meetings, aligning with typical industry trends where boards generally maintain stability unless significant performance issues or governance concerns arise.
• The ratification of a 'Big Four' accounting firm like Deloitte & Touche is standard practice across publicly traded companies, including REITs, ensuring adherence to robust auditing standards.
• While the advisory vote on executive compensation passed, the level of 'against' votes (7,525,316 shares) could be benchmarked against peer REITs to assess if shareholder dissent on compensation is higher or lower than the industry average. Without specific peer data, it's difficult to provide a definitive comparison.
• The approval of a new manager equity plan is a common mechanism for REITs and other companies to incentivize management and align their interests with shareholders, a practice widely adopted across various industries.

Corporate Governance

Stakeholder Impact

• Shareholders: The approval of all proposals, including director re-elections and executive compensation, indicates a continuation of current corporate governance and management strategies. The approval of the equity plan could dilute existing shares over time but is intended to align management incentives with shareholder value creation.
• Employees: The approval of the 2025 Manager Equity Plan provides a mechanism for equity-based compensation, which can serve as a significant incentive for attracting, retaining, and motivating employees and management.

Next Steps

• The newly elected directors will serve their one-year terms until the 2026 Annual Meeting of Stockholders.
• Deloitte & Touche LLP will continue as the independent registered public accounting firm for the year ending December 31, 2025.
• The American Healthcare REIT, Inc. 2025 Manager Equity Plan is now effective and can be utilized for employee incentives.

Key Dates

Recommendation

Keywords

American Healthcare REIT, AHR, SEC Filing, 8-K, Annual Meeting, Stockholder Vote, Director Election, Auditor Ratification, Executive Compensation, Equity Plan, Corporate Governance, REIT, Healthcare Real Estate